JAMA Oncology

Edit Your Profile

JAMA Oncology Journal

publication venue for

Efficacy of Treatment With Armodafinil for Cancer-Related Fatigue in Patients With High-grade Glioma A Phase 3 Randomized Clinical Trial. 8:259-267. 2022
Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-Adjusted life-years for 29 cancer groups, 1990 to 2017: A systematic analysis for the global burden of disease study. 5:1749-1768. 2019
Hormone Replacement Therapy After Oophorectomy and Breast Cancer Risk Among BRCA1 Mutation Carriers. 4:1059-1065. 2018
Estimating Survival in Patients With Lung Cancer and Brain Metastases An Update of the Graded Prognostic Assessment for Lung Cancer Using Molecular Markers (Lung-molGPA). 3:827-831. 2017
Molecular-Based Recursive Partitioning Analysis Model for Glioblastoma in the Temozolomide Era A Correlative Analysis Based on NRG Oncology RTOG 0525. 3:784-792. 2017
Effect of Oophorectomy on Survival After Breast Cancer in BRCA1 and BRCA2 Mutation Carriers. 1:306-313. 2015
Quality Assessment of a Systematic Review for HIV Infection and Advanced-Stage Cancer 2019
Regarding the Congruence between 2 Circulating Tumor DNA Sequencing Assays 2018
Brain Metastases in Lung Cancer With Targetable Mutations: Should We Allow Targeted Treatment in Prognostic Indices? Reply 2018
Association of MGMT Promoter Methylation Status With Survival Outcomes in Patients With High-Risk Glioma Treated With Radiotherapy and Temozolomide An Analysis From the NRG Oncology/RTOG 0424 Trial 2018
The Changing Role of Whole-Brain Radiotherapy Demise or Time for Selective Usage? 2017
The Changing Role of Whole-Brain Radiotherapy: Demise or Time for Selective Usage? (vol 3, pg 1021, 2017) 2017

International Standard Serial Number (ISSN)

2374-2437

Electronic International Standard Serial Number (EISSN)

2374-2445